SE460050B - Vasopressinanaloger med effekter paa det centrala nervsystemet - Google Patents

Vasopressinanaloger med effekter paa det centrala nervsystemet

Info

Publication number
SE460050B
SE460050B SE8302075A SE8302075A SE460050B SE 460050 B SE460050 B SE 460050B SE 8302075 A SE8302075 A SE 8302075A SE 8302075 A SE8302075 A SE 8302075A SE 460050 B SE460050 B SE 460050B
Authority
SE
Sweden
Prior art keywords
solution
dimethylformamide
compound
vase
effects
Prior art date
Application number
SE8302075A
Other languages
English (en)
Swedish (sv)
Other versions
SE8302075D0 (sv
SE8302075L (sv
Inventor
F Brtnik
T Barth
P Hrbas
K Jost
I Krejci
B Kupkova
A Machova
L Servitova
J Skopkova
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CS822803A external-priority patent/CS230315B1/cs
Priority claimed from CS830182A external-priority patent/CS231749B1/cs
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of SE8302075D0 publication Critical patent/SE8302075D0/xx
Publication of SE8302075L publication Critical patent/SE8302075L/xx
Publication of SE460050B publication Critical patent/SE460050B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8302075A 1982-04-20 1983-04-14 Vasopressinanaloger med effekter paa det centrala nervsystemet SE460050B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CS822803A CS230315B1 (cs) 1982-04-20 1982-04-20 Analogy vasopresinu a způsob jejich výroby
CS830182A CS231749B1 (cs) 1982-11-19 1982-11-19 Analog vasopresinu a způsob jeho výroby

Publications (3)

Publication Number Publication Date
SE8302075D0 SE8302075D0 (sv) 1983-04-14
SE8302075L SE8302075L (sv) 1983-10-21
SE460050B true SE460050B (sv) 1989-09-04

Family

ID=25745688

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8302075A SE460050B (sv) 1982-04-20 1983-04-14 Vasopressinanaloger med effekter paa det centrala nervsystemet

Country Status (11)

Country Link
US (1) US4482486A (da)
JP (1) JPS6485999A (da)
BE (1) BE896504A (da)
CH (1) CH653345A5 (da)
DE (1) DE3314357A1 (da)
DK (1) DK153883A (da)
FR (1) FR2525215B1 (da)
GB (1) GB2121049B (da)
IT (1) IT1164189B (da)
NL (1) NL8301320A (da)
SE (1) SE460050B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
CA1249397A (en) * 1984-03-07 1989-01-24 Fadia E. Ali Process for preparing des-proline vasopressin antagonists
US4661472A (en) * 1985-05-09 1987-04-28 The Salk Institute For Biological Studies GnRH antagonists IX
US4711877A (en) * 1985-09-18 1987-12-08 Smithkline Beckman Corporation 6-pen-vasopressin compounds
US4760052A (en) * 1986-01-16 1988-07-26 Smithkline Beckman Corporation 1,6-dicarba-vasopressin compounds
US6028168A (en) 1991-08-09 2000-02-22 Winfried Kolbeck Lanthionine bridged peptides
US5562812A (en) * 1995-04-03 1996-10-08 The Penn State Research Foundation Free flow electrophoresis device for biomolecule purification and separation in zero and one G
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
WO1999064395A1 (en) * 1998-06-11 1999-12-16 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
JO3371B1 (ar) 2013-07-26 2019-03-13 Ferring Bv ناهضات مستقبل فاسوبريسين 2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6509712A (da) * 1964-07-27 1966-01-28
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
NL167323C (nl) * 1970-09-26 1981-12-16 Organon Nv Werkwijze ter bereiding van een psychofarmacologisch preparaat.
US4261980A (en) * 1980-05-16 1981-04-14 Vega Laboratories, Inc. Method for prophylaxis and/or treatment of sickle cell disease
US4399125A (en) * 1981-03-24 1983-08-16 Maurice Manning Novel antagonists of the antidiuretic action of arginine vasopressin

Also Published As

Publication number Publication date
SE8302075D0 (sv) 1983-04-14
DE3314357A1 (de) 1983-10-27
NL8301320A (nl) 1983-11-16
BE896504A (fr) 1983-08-16
CH653345A5 (de) 1985-12-31
GB2121049B (en) 1985-04-17
JPS6485999A (en) 1989-03-30
DK153883D0 (da) 1983-04-07
IT1164189B (it) 1987-04-08
US4482486A (en) 1984-11-13
SE8302075L (sv) 1983-10-21
FR2525215B1 (fr) 1986-02-28
DK153883A (da) 1983-10-21
IT8320677A0 (it) 1983-04-19
FR2525215A1 (fr) 1983-10-21
GB2121049A (en) 1983-12-14
GB8309736D0 (en) 1983-05-18

Similar Documents

Publication Publication Date Title
Barlos et al. Efficient" one-pot" synthesis of N-tritylamino acids
McDermott et al. N-Methylamino acids in peptide synthesis. II. A new synthesis of N-benzyloxycarbonyl, N-methylamino acids
DK148905B (da) Analogifremgangsmaade til fremstilling af lh-rh-analoge nonapeptidderivater
SE460050B (sv) Vasopressinanaloger med effekter paa det centrala nervsystemet
SHIOIRI et al. Amino acids and peptides. XI. Phosphorus in organic synthesis. VI. Application of diphenyl phosphorazidate to the synthesis of peptides containing various functions
US4454065A (en) Oligopeptide prodrugs
EP0394194B1 (de) Geschützte Aminosäuren und Verfahren zu ihrer Herstellung
US4440692A (en) Substituted carbonic acid esters
SE452318B (sv) Aminosyror till anvendning som mellanprodukter vid framstellning av bestatiner
Hiskey et al. Sulfur-Containing Polypeptides. VI. Stability Studies on Unsymmetrical Open-Chain Cystine Derivatives1-3
US3076797A (en) Process of producing oxytocin and intermediates obtained thereby
IE42785B1 (en) L-3-(3,4-dihydroxyphenyl)-2-methyl-alanine peptides
US2938891A (en) Method of making oxytocin and intermediates thereof
US3749704A (en) N-(omega-amino lower alkyl)-amides of 1,17-modified acth peptides
US5312811A (en) Peptide derivatives and antidemetia agents
US4479898A (en) Oligopeptide prodrugs
HU200985B (en) Process for production of active esthers of carbonic acid
EP0094815B1 (en) Oligopeptide prodrugs
SE461042B (sv) Peptider med tillvaextbefraemjande aktivitet jaemte veterinaera kompositioner innehaallande naemnda peptider
RU2063979C1 (ru) Пептиды последовательности окситоцина
US4508645A (en) Analogs of neurohypophysial hormones with inhibition effects
SE407215B (sv) Forfarande for framstellning av peptider med psykofarmakologiska egenskaper
US4087419A (en) Heptapeptides and methods for their production
HU181402B (en) Process for preparing new peptides with psychopharmacological activity
EP0273893A2 (en) Novel compounds

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8302075-0

Effective date: 19911108

Format of ref document f/p: F